These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12357859)

  • 1. Venlafaxine: a new class of antidepressant.
    Hardy J; Argyropoulos S; Nutt DJ
    Hosp Med; 2002 Sep; 63(9):549-52. PubMed ID: 12357859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumonitis related to venlafaxine.
    Vázquez MJ; Carretero Quevedo B
    Psychosomatics; 2008; 49(1):84-5. PubMed ID: 18212183
    [No Abstract]   [Full Text] [Related]  

  • 3. Achieving remission from depression with venlafaxine and venlafaxine extended release: a literature review of comparative studies with selective serotonin reuptake inhibitors.
    Rudolph RL
    Acta Psychiatr Scand Suppl; 2002; (415):24-30. PubMed ID: 12492770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Discontinuation of antidepressant serotonergic antidepressant].
    Andersen CL; Videbech P
    Ugeskr Laeger; 2010 Jan; 172(4):296-8. PubMed ID: 20105399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharma-Clinics. The drug of the month. Venlafaxine (Efexor)].
    Ansseau M
    Rev Med Liege; 1998 Feb; 53(2):106-8. PubMed ID: 9564231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical use of venlafaxine serology to uncover genetic rapid metabolism.
    Schaller JL; Behar D
    J Neuropsychiatry Clin Neurosci; 2001; 13(1):112-3. PubMed ID: 11207339
    [No Abstract]   [Full Text] [Related]  

  • 7. Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.
    Silverstone PH; Ravindran A
    J Clin Psychiatry; 1999 Jan; 60(1):22-8. PubMed ID: 10074873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of depression with different formulations of venlafaxine: a comparative analysis.
    Olver JS; Burrows GD; Norman TR
    Hum Psychopharmacol; 2004 Jan; 19(1):9-16. PubMed ID: 14716706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venlafaxine XR in the treatment of anxiety.
    Hackett D
    Acta Psychiatr Scand Suppl; 2000; (406):30-5. PubMed ID: 11131468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withdrawal and rebound symptoms associated with abrupt discontinuation of venlafaxine.
    Dallal A; Chouinard G
    J Clin Psychopharmacol; 1998 Aug; 18(4):343-4. PubMed ID: 9690703
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypokalemia with venlafaxine.
    Shang CY; Soong WT; Lin HN
    J Clin Psychiatry; 2002 Nov; 63(11):1049-50. PubMed ID: 12469691
    [No Abstract]   [Full Text] [Related]  

  • 12. Remission of traumatic brain injury-induced compulsions during venlafaxine treatment.
    Khouzam HR; Donnelly NJ
    Gen Hosp Psychiatry; 1998 Jan; 20(1):62-3. PubMed ID: 9506256
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.
    Serres F; Millan MJ; Sharp T
    Int J Neuropsychopharmacol; 2012 Jun; 15(5):617-29. PubMed ID: 21733241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venlafaxine: loss of antidepressant effect and its management.
    Sharma V
    J Clin Psychiatry; 1998 Jul; 59(7):381-2. PubMed ID: 9714268
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid onset of action of venlafaxine.
    Montgomery SA
    Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 2():21-7. PubMed ID: 7622814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder.
    Rickels K; Pollack MH; Sheehan DV; Haskins JT
    Am J Psychiatry; 2000 Jun; 157(6):968-74. PubMed ID: 10831478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute adverse cutaneous reaction after the concomitant use of venlafaxine and orphenadrine citrate plus paracetamol in a depressed patient.
    Papadimitriou GN; Theleritis CG; Papageorgiou CC; Kalogeromitros D; Syrigou E; Gregoriou S; Rabavilas AD
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):1019. PubMed ID: 16922966
    [No Abstract]   [Full Text] [Related]  

  • 18. Attaining remission in generalized anxiety disorder: venlafaxine extended release comparative data.
    Sheehan DV
    J Clin Psychiatry; 2001; 62 Suppl 19():26-31. PubMed ID: 11577788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic options for treating major depression, and the role of venlafaxine.
    Scott MA; Shelton PS; Gattis W
    Pharmacotherapy; 1996; 16(3):352-65. PubMed ID: 8726593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of the effects of venlafaxine on anxiety associated with depression.
    Rudolph RL; Entsuah R; Chitra R
    J Clin Psychopharmacol; 1998 Apr; 18(2):136-44. PubMed ID: 9555599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.